

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | acrosome reaction (GO:0007340) | 9.44809638 |
| 2 | cell wall macromolecule metabolic process (GO:0044036) | 9.17660422 |
| 3 | cell wall macromolecule catabolic process (GO:0016998) | 9.17660422 |
| 4 | sperm-egg recognition (GO:0035036) | 8.82376635 |
| 5 | acrosome assembly (GO:0001675) | 8.67246717 |
| 6 | multicellular organism reproduction (GO:0032504) | 8.31836668 |
| 7 | cilium or flagellum-dependent cell motility (GO:0001539) | 8.22816613 |
| 8 | cell-cell recognition (GO:0009988) | 8.09982995 |
| 9 | binding of sperm to zona pellucida (GO:0007339) | 7.95755966 |
| 10 | axonemal dynein complex assembly (GO:0070286) | 7.93978963 |
| 11 | plasma membrane fusion (GO:0045026) | 7.48616439 |
| 12 | motile cilium assembly (GO:0044458) | 7.41427894 |
| 13 | epithelial cilium movement (GO:0003351) | 7.30306585 |
| 14 | reproduction (GO:0000003) | 7.21225889 |
| 15 | * spermatid development (GO:0007286) | 7.13424399 |
| 16 | cilium movement (GO:0003341) | 6.13479537 |
| 17 | piRNA metabolic process (GO:0034587) | 6.10846957 |
| 18 | regulation of cilium movement (GO:0003352) | 6.08208987 |
| 19 | organic cation transport (GO:0015695) | 5.69158652 |
| 20 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.64016224 |
| 21 | male meiosis (GO:0007140) | 5.60841923 |
| 22 | negative regulation of inclusion body assembly (GO:0090084) | 5.58129584 |
| 23 | single fertilization (GO:0007338) | 5.53650100 |
| 24 | synaptonemal complex organization (GO:0070193) | 5.51326470 |
| 25 | synaptonemal complex assembly (GO:0007130) | 5.34797099 |
| 26 | sperm capacitation (GO:0048240) | 5.32347844 |
| 27 | spermatogenesis (GO:0007283) | 5.08460770 |
| 28 | NIK/NF-kappaB signaling (GO:0038061) | 5.06335048 |
| 29 | male gamete generation (GO:0048232) | 5.06105154 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 4.99225483 |
| 31 | response to peptidoglycan (GO:0032494) | 4.95361673 |
| 32 | fertilization (GO:0009566) | 4.84801013 |
| 33 | gamete generation (GO:0007276) | 4.62284883 |
| 34 | interferon-gamma secretion (GO:0072643) | 4.59952689 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 4.58108306 |
| 36 | regulation of inclusion body assembly (GO:0090083) | 4.45400473 |
| 37 | natural killer cell mediated immunity (GO:0002228) | 4.10709965 |
| 38 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.10709965 |
| 39 | ventricular system development (GO:0021591) | 4.10677871 |
| 40 | * cellular process involved in reproduction in multicellular organism (GO:0022412) | 4.06701659 |
| 41 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.02665105 |
| 42 | seminiferous tubule development (GO:0072520) | 4.00637185 |
| 43 | * germ cell development (GO:0007281) | 3.93104297 |
| 44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.89869355 |
| 45 | DNA methylation involved in gamete generation (GO:0043046) | 3.79341783 |
| 46 | male meiosis I (GO:0007141) | 3.79315192 |
| 47 | sequestering of actin monomers (GO:0042989) | 3.70335412 |
| 48 | RNA destabilization (GO:0050779) | 3.67215653 |
| 49 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.62375044 |
| 50 | positive regulation of type 2 immune response (GO:0002830) | 3.61753158 |
| 51 | multicellular organismal reproductive process (GO:0048609) | 3.60251976 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 3.57887679 |
| 53 | cell recognition (GO:0008037) | 3.57392931 |
| 54 | T-helper 1 type immune response (GO:0042088) | 3.57151158 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.54926268 |
| 56 | calcium ion-dependent exocytosis (GO:0017156) | 3.50665606 |
| 57 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.48428354 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48395832 |
| 59 | regulation of microtubule-based movement (GO:0060632) | 3.47582111 |
| 60 | left/right pattern formation (GO:0060972) | 3.47501244 |
| 61 | chromosome organization involved in meiosis (GO:0070192) | 3.46565178 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39610897 |
| 63 | regulation of mast cell degranulation (GO:0043304) | 3.37627623 |
| 64 | sexual reproduction (GO:0019953) | 3.34088163 |
| 65 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.33761317 |
| 66 | negative regulation of cell killing (GO:0031342) | 3.33761317 |
| 67 | microtubule depolymerization (GO:0007019) | 3.33660993 |
| 68 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.33087102 |
| 69 | glycosphingolipid catabolic process (GO:0046479) | 3.27555153 |
| 70 | regulation of mononuclear cell migration (GO:0071675) | 3.26792564 |
| 71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26488461 |
| 72 | amino-acid betaine transport (GO:0015838) | 3.22251389 |
| 73 | carnitine transport (GO:0015879) | 3.22251389 |
| 74 | germinal center formation (GO:0002467) | 3.19535795 |
| 75 | granulocyte activation (GO:0036230) | 3.18919933 |
| 76 | macrophage activation (GO:0042116) | 3.18917870 |
| 77 | chromosome condensation (GO:0030261) | 3.18339225 |
| 78 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.17348291 |
| 79 | detection of other organism (GO:0098543) | 3.16483601 |
| 80 | glycerol ether metabolic process (GO:0006662) | 3.13737593 |
| 81 | amino sugar catabolic process (GO:0046348) | 3.11366307 |
| 82 | DNA packaging (GO:0006323) | 3.10971058 |
| 83 | type I interferon signaling pathway (GO:0060337) | 3.10745328 |
| 84 | cellular response to type I interferon (GO:0071357) | 3.10745328 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10320944 |
| 86 | carnitine transmembrane transport (GO:1902603) | 3.10109883 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 3.07449940 |
| 88 | response to type I interferon (GO:0034340) | 3.06699514 |
| 89 | positive regulation of mast cell degranulation (GO:0043306) | 3.06248962 |
| 90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.06248962 |
| 91 | oligosaccharide catabolic process (GO:0009313) | 3.05746436 |
| 92 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.03569920 |
| 93 | detection of external biotic stimulus (GO:0098581) | 3.03022855 |
| 94 | membrane protein intracellular domain proteolysis (GO:0031293) | 3.02897957 |
| 95 | microtubule severing (GO:0051013) | 3.00690804 |
| 96 | positive regulation of antigen processing and presentation (GO:0002579) | 3.00466203 |
| 97 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.98746508 |
| 98 | positive regulation of mast cell activation (GO:0033005) | 2.98076651 |
| 99 | regulation of gamma-delta T cell activation (GO:0046643) | 2.98005529 |
| 100 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.97695242 |
| 101 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.97032789 |
| 102 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96732474 |
| 103 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95704022 |
| 104 | meiotic nuclear division (GO:0007126) | 2.94227434 |
| 105 | regulation of protein polyubiquitination (GO:1902914) | 2.93879365 |
| 106 | defense response to protozoan (GO:0042832) | 2.93786630 |
| 107 | neutrophil activation (GO:0042119) | 2.92975058 |
| 108 | regulation of leukocyte degranulation (GO:0043300) | 2.92634550 |
| 109 | glycolipid catabolic process (GO:0019377) | 2.91940243 |
| 110 | genitalia morphogenesis (GO:0035112) | 2.91513357 |
| 111 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.91337549 |
| 112 | multicellular organismal development (GO:0007275) | 2.91223685 |
| 113 | fructose metabolic process (GO:0006000) | 2.91097137 |
| 114 | cellular extravasation (GO:0045123) | 2.90285498 |
| 115 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.90127247 |
| 116 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.90127247 |
| 117 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.89599084 |
| 118 | detection of bacterium (GO:0016045) | 2.89023923 |
| 119 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.87935189 |
| 120 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.85774545 |
| 121 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.85680321 |
| 122 | ether metabolic process (GO:0018904) | 2.84746565 |
| 123 | microglial cell activation (GO:0001774) | 2.84504939 |
| 124 | meiosis I (GO:0007127) | 2.82733841 |
| 125 | regulation of interferon-alpha production (GO:0032647) | 2.81932275 |
| 126 | immunoglobulin mediated immune response (GO:0016064) | 2.81766987 |
| 127 | lymphocyte chemotaxis (GO:0048247) | 2.81753346 |
| 128 | response to protozoan (GO:0001562) | 2.81692678 |
| 129 | peptide catabolic process (GO:0043171) | 2.79837817 |
| 130 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.78371826 |
| 131 | regulation of vitamin metabolic process (GO:0030656) | 2.77282790 |
| 132 | positive regulation of leukocyte degranulation (GO:0043302) | 2.77142980 |
| 133 | regulation of type 2 immune response (GO:0002828) | 2.76052270 |
| 134 | negative regulation of necroptotic process (GO:0060546) | 2.72959827 |
| 135 | detection of biotic stimulus (GO:0009595) | 2.72697128 |
| 136 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71617354 |
| 137 | modulation by symbiont of host defense response (GO:0052031) | 2.71617354 |
| 138 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71617354 |
| 139 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71617354 |
| 140 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71617354 |
| 141 | modulation by symbiont of host immune response (GO:0052553) | 2.71617354 |
| 142 | regulation of necroptotic process (GO:0060544) | 2.71504245 |
| 143 | leukocyte mediated cytotoxicity (GO:0001909) | 2.71073229 |
| 144 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.70202921 |
| 145 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.69741836 |
| 146 | negative regulation of granulocyte differentiation (GO:0030853) | 2.69447966 |
| 147 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.69243692 |
| 148 | regulation of mast cell activation (GO:0033003) | 2.68453637 |
| 149 | regulation of interleukin-12 production (GO:0032655) | 2.68283156 |
| 150 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.67818390 |
| 151 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.67678691 |
| 152 | response to acidic pH (GO:0010447) | 2.65822990 |
| 153 | N-acetylneuraminate metabolic process (GO:0006054) | 2.65813943 |
| 154 | regulation of antigen processing and presentation (GO:0002577) | 2.65226840 |
| 155 | regulation of macrophage chemotaxis (GO:0010758) | 2.63727899 |
| 156 | response to interferon-gamma (GO:0034341) | 2.61912196 |
| 157 | regulation of T cell tolerance induction (GO:0002664) | 2.61714820 |
| 158 | regulation of podosome assembly (GO:0071801) | 2.61545140 |
| 159 | regulation of chemokine biosynthetic process (GO:0045073) | 2.60002712 |
| 160 | neutrophil activation involved in immune response (GO:0002283) | 2.59100365 |
| 161 | response to thyroid hormone (GO:0097066) | 2.57241079 |
| 162 | cellular response to lipopolysaccharide (GO:0071222) | 2.56252188 |
| 163 | cellular response to molecule of bacterial origin (GO:0071219) | 2.56194296 |
| 164 | response to muramyl dipeptide (GO:0032495) | 2.56140548 |
| 165 | cellular response to interferon-gamma (GO:0071346) | 2.55855356 |
| 166 | meiotic cell cycle (GO:0051321) | 2.54796876 |
| 167 | myeloid leukocyte activation (GO:0002274) | 2.54576926 |
| 168 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.52807180 |
| 169 | low-density lipoprotein particle clearance (GO:0034383) | 2.50510778 |
| 170 | protein localization to cilium (GO:0061512) | 2.48399947 |
| 171 | cytokine secretion (GO:0050663) | 2.47774161 |
| 172 | myeloid dendritic cell differentiation (GO:0043011) | 2.47260263 |
| 173 | spermatid nucleus differentiation (GO:0007289) | 2.44214732 |
| 174 | positive regulation of interferon-alpha production (GO:0032727) | 2.42155381 |
| 175 | cellular response to arsenic-containing substance (GO:0071243) | 2.41120459 |
| 176 | ruffle organization (GO:0031529) | 2.40923763 |
| 177 | sperm motility (GO:0030317) | 10.6004270 |
| 178 | fusion of sperm to egg plasma membrane (GO:0007342) | 10.0969309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 6.68912652 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.67200727 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.63755380 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.31687831 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.05895471 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.75996084 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.75704764 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.39502677 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.34179910 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.28356591 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.23575199 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.17925458 |
| 13 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.17686577 |
| 14 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.12297367 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.10699440 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09684787 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.07075862 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99487528 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96539537 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.93796669 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93463931 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.90082657 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89002454 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81860399 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81684297 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78273691 |
| 27 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.71397016 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70751714 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68697405 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.64603029 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60287520 |
| 32 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.58149467 |
| 33 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56903203 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56703197 |
| 35 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56543579 |
| 36 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.55554677 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53454114 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50722762 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.49592704 |
| 40 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49281364 |
| 41 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48880838 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.46490581 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46040218 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.45376096 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44756837 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43962183 |
| 47 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43234789 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42757314 |
| 49 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40099849 |
| 50 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.39928437 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38367858 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37250828 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35231114 |
| 54 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35222477 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35137196 |
| 56 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.34148095 |
| 57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.31623274 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30011928 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29592994 |
| 60 | P68_20966046_ChIP-Seq_HELA_Human | 1.28524084 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28316248 |
| 62 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28231724 |
| 63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27395365 |
| 64 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.26325648 |
| 65 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26216369 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26115978 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25727640 |
| 68 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24957595 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24021337 |
| 70 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22712611 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22475156 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20936533 |
| 73 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20870760 |
| 74 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20548616 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19743916 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18765656 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.18533920 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18499573 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18141375 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 1.17978731 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17345022 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16929540 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16729512 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16271959 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16216761 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.15228996 |
| 87 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13286029 |
| 88 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12362975 |
| 89 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12293094 |
| 90 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12134979 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12078918 |
| 92 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.11295747 |
| 93 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.10873608 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09015428 |
| 95 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07839170 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07725778 |
| 97 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07352089 |
| 98 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07102446 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06941955 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06846709 |
| 101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06840447 |
| 102 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.06371688 |
| 103 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05494802 |
| 104 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04384874 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03727244 |
| 106 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.03213965 |
| 107 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.02051798 |
| 108 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.01772141 |
| 109 | MYB_26560356_Chip-Seq_TH2_Human | 1.01234995 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01054244 |
| 111 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.00113662 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99908681 |
| 113 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99519403 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99362107 |
| 115 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.98925287 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.98866975 |
| 117 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.98301651 |
| 118 | MYC_22102868_ChIP-Seq_BL_Human | 0.98066872 |
| 119 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.97878282 |
| 120 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97853723 |
| 121 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.96931212 |
| 122 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96390120 |
| 123 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96390120 |
| 124 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96262347 |
| 125 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96105392 |
| 126 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96105392 |
| 127 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95642592 |
| 128 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95307797 |
| 129 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95124946 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93980740 |
| 131 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93725237 |
| 132 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93353213 |
| 133 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92944145 |
| 134 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92778051 |
| 135 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.92202138 |
| 136 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91729156 |
| 137 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.91728202 |
| 138 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.91248410 |
| 139 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90955512 |
| 140 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90955512 |
| 141 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90876363 |
| 142 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.90300247 |
| 143 | MYB_26560356_Chip-Seq_TH1_Human | 0.90090737 |
| 144 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88893353 |
| 145 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88610431 |
| 146 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88203183 |
| 147 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.88111027 |
| 148 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87942818 |
| 149 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.87481205 |
| 150 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.87478485 |
| 151 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.87431599 |
| 152 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.87323542 |
| 153 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.85674525 |
| 154 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.85087769 |
| 155 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.85033573 |
| 156 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.84237816 |
| 157 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.83543042 |
| 158 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83157550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.01206522 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 3.84595270 |
| 3 | * MP0003698_abnormal_male_reproductive | 3.40606036 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.38762143 |
| 5 | * MP0001929_abnormal_gametogenesis | 3.11777848 |
| 6 | MP0004510_myositis | 2.87556498 |
| 7 | MP0000685_abnormal_immune_system | 2.54990757 |
| 8 | MP0003436_decreased_susceptibility_to | 2.48853830 |
| 9 | MP0005670_abnormal_white_adipose | 2.36981283 |
| 10 | MP0005451_abnormal_body_composition | 2.28867936 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.15378597 |
| 12 | MP0005410_abnormal_fertilization | 10.5906803 |
| 13 | MP0001348_abnormal_lacrimal_gland | 1.94724742 |
| 14 | MP0000569_abnormal_digit_pigmentation | 1.92726705 |
| 15 | MP0001790_abnormal_immune_system | 1.89447717 |
| 16 | MP0005387_immune_system_phenotype | 1.89447717 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 1.87612287 |
| 18 | MP0000343_altered_response_to | 1.86340670 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.85151845 |
| 20 | MP0009785_altered_susceptibility_to | 1.77916487 |
| 21 | * MP0002161_abnormal_fertility/fecundity | 1.74732506 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.73290019 |
| 23 | MP0002210_abnormal_sex_determination | 1.73012509 |
| 24 | * MP0002419_abnormal_innate_immunity | 1.70110659 |
| 25 | MP0005025_abnormal_response_to | 1.70040475 |
| 26 | MP0001800_abnormal_humoral_immune | 1.65107376 |
| 27 | MP0006082_CNS_inflammation | 1.62455947 |
| 28 | MP0008004_abnormal_stomach_pH | 1.59909405 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.59449856 |
| 30 | MP0002723_abnormal_immune_serum | 1.53584185 |
| 31 | * MP0002452_abnormal_antigen_presenting | 1.52255705 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.51947228 |
| 33 | MP0003690_abnormal_glial_cell | 1.51524432 |
| 34 | MP0003303_peritoneal_inflammation | 1.50211969 |
| 35 | MP0005166_decreased_susceptibility_to | 1.47781596 |
| 36 | MP0005310_abnormal_salivary_gland | 1.45433532 |
| 37 | MP0001873_stomach_inflammation | 1.44823825 |
| 38 | MP0000604_amyloidosis | 1.44212788 |
| 39 | * MP0001145_abnormal_male_reproductive | 1.43043749 |
| 40 | MP0004947_skin_inflammation | 1.38909383 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.33344380 |
| 42 | MP0002405_respiratory_system_inflammati | 1.31441984 |
| 43 | MP0005360_urolithiasis | 1.31155350 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.30753357 |
| 45 | MP0005671_abnormal_response_to | 1.29716018 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.24989345 |
| 47 | * MP0001819_abnormal_immune_cell | 1.22701650 |
| 48 | MP0003828_pulmonary_edema | 1.20400244 |
| 49 | * MP0002420_abnormal_adaptive_immunity | 1.20097392 |
| 50 | MP0008469_abnormal_protein_level | 1.18875366 |
| 51 | MP0008260_abnormal_autophagy | 1.17853624 |
| 52 | MP0003329_amyloid_beta_deposits | 1.17844557 |
| 53 | MP0001853_heart_inflammation | 1.17314194 |
| 54 | * MP0000653_abnormal_sex_gland | 1.15674553 |
| 55 | MP0002006_tumorigenesis | 1.14267581 |
| 56 | MP0009278_abnormal_bone_marrow | 1.14036968 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.13899460 |
| 58 | MP0009840_abnormal_foam_cell | 1.12183574 |
| 59 | MP0003448_altered_tumor_morphology | 1.11517538 |
| 60 | MP0003724_increased_susceptibility_to | 1.11112563 |
| 61 | MP0005164_abnormal_response_to | 1.09482837 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.08904656 |
| 63 | MP0003195_calcinosis | 1.08199899 |
| 64 | MP0003878_abnormal_ear_physiology | 1.07715390 |
| 65 | MP0005377_hearing/vestibular/ear_phenot | 1.07715390 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.06628618 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.06628618 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.04819217 |
| 69 | MP0002132_abnormal_respiratory_system | 1.04212112 |
| 70 | MP0003252_abnormal_bile_duct | 1.02551579 |
| 71 | MP0003300_gastrointestinal_ulcer | 1.02380586 |
| 72 | MP0009764_decreased_sensitivity_to | 1.02123235 |
| 73 | MP0003172_abnormal_lysosome_physiology | 0.99388271 |
| 74 | MP0005464_abnormal_platelet_physiology | 0.99096873 |
| 75 | MP0004883_abnormal_blood_vessel | 0.97318180 |
| 76 | MP0000678_abnormal_parathyroid_gland | 0.97057655 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.96256380 |
| 78 | MP0002332_abnormal_exercise_endurance | 0.95123550 |
| 79 | MP0003646_muscle_fatigue | 0.94376054 |
| 80 | MP0005647_abnormal_sex_gland | 0.94234447 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.93954643 |
| 82 | MP0000920_abnormal_myelination | 0.92749477 |
| 83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91895271 |
| 84 | MP0005365_abnormal_bile_salt | 0.91771874 |
| 85 | MP0000716_abnormal_immune_system | 0.90702356 |
| 86 | MP0005390_skeleton_phenotype | 0.88819681 |
| 87 | MP0000609_abnormal_liver_physiology | 0.86825131 |
| 88 | MP0002009_preneoplasia | 0.86623401 |
| 89 | MP0003045_fibrosis | 0.84081911 |
| 90 | MP0005623_abnormal_meninges_morphology | 0.83802614 |
| 91 | MP0001346_abnormal_lacrimal_gland | 0.81887793 |
| 92 | MP0002933_joint_inflammation | 0.81171984 |
| 93 | * MP0000249_abnormal_blood_vessel | 0.79899234 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.79848275 |
| 95 | MP0002295_abnormal_pulmonary_circulatio | 0.79025551 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.78793316 |
| 97 | MP0002398_abnormal_bone_marrow | 0.77279078 |
| 98 | MP0002653_abnormal_ependyma_morphology | 0.75870062 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.74856607 |
| 100 | MP0008874_decreased_physiological_sensi | 0.74584356 |
| 101 | MP0010307_abnormal_tumor_latency | 0.74276473 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.74151396 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.73240265 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.73173593 |
| 105 | MP0003795_abnormal_bone_structure | 0.73113164 |
| 106 | MP0004019_abnormal_vitamin_homeostasis | 0.72472168 |
| 107 | MP0002722_abnormal_immune_system | 0.72177715 |
| 108 | MP0005085_abnormal_gallbladder_physiolo | 0.72060101 |
| 109 | MP0003091_abnormal_cell_migration | 0.71306703 |
| 110 | MP0005083_abnormal_biliary_tract | 0.70874214 |
| 111 | MP0006054_spinal_hemorrhage | 0.70562954 |
| 112 | MP0003879_abnormal_hair_cell | 0.70006349 |
| 113 | MP0001851_eye_inflammation | 0.69347311 |
| 114 | MP0002429_abnormal_blood_cell | 0.68666541 |
| 115 | MP0009763_increased_sensitivity_to | 0.67519863 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.66781870 |
| 117 | MP0001849_ear_inflammation | 0.64593137 |
| 118 | MP0002998_abnormal_bone_remodeling | 0.64554021 |
| 119 | MP0002928_abnormal_bile_duct | 0.64047358 |
| 120 | MP0000689_abnormal_spleen_morphology | 0.63237285 |
| 121 | MP0001663_abnormal_digestive_system | 0.63236031 |
| 122 | MP0005535_abnormal_body_temperature | 0.63057315 |
| 123 | MP0000858_altered_metastatic_potential | 0.62152184 |
| 124 | MP0005023_abnormal_wound_healing | 0.61599355 |
| 125 | MP0005165_increased_susceptibility_to | 0.61543527 |
| 126 | MP0002971_abnormal_brown_adipose | 0.60271788 |
| 127 | MP0003705_abnormal_hypodermis_morpholog | 0.59741078 |
| 128 | MP0009115_abnormal_fat_cell | 0.58153434 |
| 129 | MP0002160_abnormal_reproductive_system | 0.56819224 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.56518508 |
| 131 | MP0010329_abnormal_lipoprotein_level | 0.56187988 |
| 132 | MP0002163_abnormal_gland_morphology | 0.56168168 |
| 133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56152841 |
| 134 | MP0003566_abnormal_cell_adhesion | 0.55988675 |
| 135 | MP0003075_altered_response_to | 0.54441080 |
| 136 | MP0003453_abnormal_keratinocyte_physiol | 0.54159825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal respiratory motile cilium physiology (HP:0012261) | 7.49344378 |
| 2 | Abnormal respiratory epithelium morphology (HP:0012253) | 7.26559134 |
| 3 | Abnormal respiratory motile cilium morphology (HP:0005938) | 7.26559134 |
| 4 | Nasal polyposis (HP:0100582) | 7.23035917 |
| 5 | Rhinitis (HP:0012384) | 6.29934483 |
| 6 | Abnormality of the nasal mucosa (HP:0000433) | 6.19375719 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.01180087 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.01180087 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 6.01180087 |
| 10 | Chronic bronchitis (HP:0004469) | 5.91586545 |
| 11 | Abnormal ciliary motility (HP:0012262) | 5.76989835 |
| 12 | Infertility (HP:0000789) | 5.66466160 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 4.38061747 |
| 14 | Bronchitis (HP:0012387) | 4.32123519 |
| 15 | Bronchiectasis (HP:0002110) | 4.19926027 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 4.08911420 |
| 17 | Dysostosis multiplex (HP:0000943) | 4.02456781 |
| 18 | Disinhibition (HP:0000734) | 3.52461397 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.50719893 |
| 20 | Male infertility (HP:0003251) | 3.41434063 |
| 21 | Recurrent bronchitis (HP:0002837) | 3.25814835 |
| 22 | Nephronophthisis (HP:0000090) | 3.25036577 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.21756947 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.21756947 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.21756947 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.18302224 |
| 27 | Recurrent sinusitis (HP:0011108) | 3.11877781 |
| 28 | Axonal loss (HP:0003447) | 3.10346985 |
| 29 | Recurrent abscess formation (HP:0002722) | 3.07625034 |
| 30 | Stomatitis (HP:0010280) | 3.04285014 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.02653983 |
| 32 | Mucopolysacchariduria (HP:0008155) | 3.02653983 |
| 33 | Obstructive lung disease (HP:0006536) | 3.01550545 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01550545 |
| 35 | Mutism (HP:0002300) | 2.98794061 |
| 36 | Nuclear cataract (HP:0100018) | 2.87481191 |
| 37 | Eczematoid dermatitis (HP:0000976) | 2.85866750 |
| 38 | Purpura (HP:0000979) | 2.84909629 |
| 39 | Severe visual impairment (HP:0001141) | 2.83042587 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.81429737 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.80309444 |
| 42 | Recurrent otitis media (HP:0000403) | 2.70259553 |
| 43 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.68959174 |
| 44 | Loss of speech (HP:0002371) | 2.67341751 |
| 45 | Increased serum ferritin (HP:0003281) | 2.65843207 |
| 46 | Myocardial infarction (HP:0001658) | 2.65161536 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.64620962 |
| 48 | Abnormality of the renal medulla (HP:0100957) | 2.60848097 |
| 49 | Tubular atrophy (HP:0000092) | 2.59485325 |
| 50 | Orchitis (HP:0100796) | 2.57225411 |
| 51 | Malnutrition (HP:0004395) | 2.54926891 |
| 52 | Retrobulbar optic neuritis (HP:0100654) | 2.54655551 |
| 53 | Optic neuritis (HP:0100653) | 2.54655551 |
| 54 | Tubulointerstitial fibrosis (HP:0005576) | 2.44432043 |
| 55 | Tetraparesis (HP:0002273) | 2.43496835 |
| 56 | Hemoptysis (HP:0002105) | 2.43101597 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.40511924 |
| 58 | Progressive neurologic deterioration (HP:0002344) | 2.35462790 |
| 59 | Complement deficiency (HP:0004431) | 2.32745253 |
| 60 | Myositis (HP:0100614) | 2.31129761 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.31045270 |
| 62 | Tubulointerstitial abnormality (HP:0001969) | 2.29587940 |
| 63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27717902 |
| 64 | Neuronal loss in central nervous system (HP:0002529) | 2.27563909 |
| 65 | Glomerulonephritis (HP:0000099) | 2.25735773 |
| 66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22718103 |
| 67 | Thin bony cortex (HP:0002753) | 2.19008860 |
| 68 | Enlarged epiphyses (HP:0010580) | 2.17985491 |
| 69 | Abnormality of complement system (HP:0005339) | 2.15989252 |
| 70 | Interstitial pulmonary disease (HP:0006530) | 2.14134897 |
| 71 | Colitis (HP:0002583) | 2.13656424 |
| 72 | Gangrene (HP:0100758) | 2.12163167 |
| 73 | Meningitis (HP:0001287) | 2.10552801 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.09516302 |
| 75 | Personality changes (HP:0000751) | 2.09132326 |
| 76 | Protuberant abdomen (HP:0001538) | 2.08973131 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.08798709 |
| 78 | Metaphyseal irregularity (HP:0003025) | 2.08446365 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.08371029 |
| 80 | Fatigue (HP:0012378) | 2.07995340 |
| 81 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.06959889 |
| 82 | Chronic sinusitis (HP:0011109) | 2.06223193 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.05974383 |
| 84 | Widely patent fontanelles and sutures (HP:0004492) | 2.05712710 |
| 85 | Abnormality of the costochondral junction (HP:0000919) | 2.03931877 |
| 86 | Spastic tetraparesis (HP:0001285) | 2.03119135 |
| 87 | Pathologic fracture (HP:0002756) | 2.02027544 |
| 88 | Peripheral demyelination (HP:0011096) | 2.01876810 |
| 89 | Apathy (HP:0000741) | 2.01213520 |
| 90 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 10.6361574 |
| 91 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 10.5977034 |
| 92 | Absent/shortened dynein arms (HP:0200106) | 10.5977034 |
| 93 | Petechiae (HP:0000967) | 1.99361600 |
| 94 | Retinal atrophy (HP:0001105) | 1.99348259 |
| 95 | Recurrent skin infections (HP:0001581) | 1.99051439 |
| 96 | Polyneuropathy (HP:0001271) | 1.98582792 |
| 97 | Recurrent fungal infections (HP:0002841) | 1.97850331 |
| 98 | Diminished motivation (HP:0000745) | 1.97162163 |
| 99 | Impulsivity (HP:0100710) | 1.96416849 |
| 100 | Thick nail (HP:0001805) | 1.92714853 |
| 101 | Nephritis (HP:0000123) | 1.91808316 |
| 102 | Episodic fever (HP:0001954) | 1.91746477 |
| 103 | Chronic otitis media (HP:0000389) | 1.91413352 |
| 104 | Prolonged neonatal jaundice (HP:0006579) | 1.91178157 |
| 105 | Mediastinal lymphadenopathy (HP:0100721) | 1.89738281 |
| 106 | Acne (HP:0001061) | 1.89491078 |
| 107 | Pulmonary embolism (HP:0002204) | 1.89111147 |
| 108 | Dementia (HP:0000726) | 1.88946322 |
| 109 | Gingivitis (HP:0000230) | 1.88759667 |
| 110 | Increased IgE level (HP:0003212) | 1.87200857 |
| 111 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87069250 |
| 112 | Urticaria (HP:0001025) | 1.86595928 |
| 113 | Tubulointerstitial nephritis (HP:0001970) | 1.85729136 |
| 114 | Hypercholesterolemia (HP:0003124) | 1.84607310 |
| 115 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84132478 |
| 116 | Abnormality of macrophages (HP:0004311) | 1.83935080 |
| 117 | Premature loss of primary teeth (HP:0006323) | 1.83091614 |
| 118 | Polycythemia (HP:0001901) | 1.83018315 |
| 119 | Abnormal gallbladder physiology (HP:0012438) | 1.82830418 |
| 120 | Cholecystitis (HP:0001082) | 1.82830418 |
| 121 | Gonadotropin excess (HP:0000837) | 1.81940546 |
| 122 | Glomerulopathy (HP:0100820) | 1.81393627 |
| 123 | Generalized aminoaciduria (HP:0002909) | 1.81208551 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80302822 |
| 125 | Increased CSF protein (HP:0002922) | 1.79428066 |
| 126 | Arterial thrombosis (HP:0004420) | 1.79125986 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.77008054 |
| 128 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.77008054 |
| 129 | Periodontitis (HP:0000704) | 1.75593933 |
| 130 | Absent frontal sinuses (HP:0002688) | 1.74101318 |
| 131 | Vascular calcification (HP:0004934) | 1.73858775 |
| 132 | Asymmetric septal hypertrophy (HP:0001670) | 1.69147597 |
| 133 | Inflammation of the large intestine (HP:0002037) | 1.68182829 |
| 134 | Abnormal drinking behavior (HP:0030082) | 1.67841571 |
| 135 | Polydipsia (HP:0001959) | 1.67841571 |
| 136 | Deformed sella turcica (HP:0002681) | 1.67498163 |
| 137 | Congenital hepatic fibrosis (HP:0002612) | 1.66889883 |
| 138 | Keratoconjunctivitis (HP:0001096) | 1.66687088 |
| 139 | Esophageal varix (HP:0002040) | 1.65355808 |
| 140 | Upper motor neuron abnormality (HP:0002127) | 1.65290720 |
| 141 | Amyloidosis (HP:0011034) | 1.64846220 |
| 142 | Vasculitis (HP:0002633) | 1.64347176 |
| 143 | Recurrent viral infections (HP:0004429) | 1.62991732 |
| 144 | Choroideremia (HP:0001139) | 1.62921476 |
| 145 | J-shaped sella turcica (HP:0002680) | 1.62551705 |
| 146 | Abnormality of renal excretion (HP:0011036) | 1.61878597 |
| 147 | * Abnormal spermatogenesis (HP:0008669) | 1.60467282 |
| 148 | Hypergammaglobulinemia (HP:0010702) | 1.55458579 |
| 149 | Keratoconjunctivitis sicca (HP:0001097) | 1.55087895 |
| 150 | Porencephaly (HP:0002132) | 1.55047433 |
| 151 | Cardiovascular calcification (HP:0011915) | 1.52542100 |
| 152 | Hematochezia (HP:0002573) | 1.52069893 |
| 153 | Gastrointestinal inflammation (HP:0004386) | 1.51942738 |
| 154 | Pulmonary infiltrates (HP:0002113) | 1.51799505 |
| 155 | Stroke (HP:0001297) | 1.50202549 |
| 156 | Cerebral inclusion bodies (HP:0100314) | 1.49722844 |
| 157 | Stage 5 chronic kidney disease (HP:0003774) | 1.47143872 |
| 158 | Abnormality of the renal cortex (HP:0011035) | 1.44701705 |
| 159 | Short nail (HP:0001799) | 1.43791552 |
| 160 | Dyschromatopsia (HP:0007641) | 1.41954647 |
| 161 | Peritonitis (HP:0002586) | 1.41597252 |
| 162 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.40566168 |
| 163 | Recurrent cutaneous fungal infections (HP:0011370) | 1.40566168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK1 | 6.35877884 |
| 2 | PDK4 | 5.53941005 |
| 3 | PDK3 | 5.53941005 |
| 4 | ICK | 3.92359991 |
| 5 | PRKD3 | 3.71419286 |
| 6 | PDK2 | 3.68986649 |
| 7 | DDR2 | 3.62232682 |
| 8 | MAP3K14 | 3.28318864 |
| 9 | TYK2 | 2.59288725 |
| 10 | MAP3K11 | 2.47188868 |
| 11 | TBK1 | 2.35778530 |
| 12 | EPHB1 | 2.25775618 |
| 13 | PTK2B | 2.18535003 |
| 14 | GRK7 | 2.08147237 |
| 15 | NME2 | 1.98864929 |
| 16 | IKBKB | 1.88117243 |
| 17 | RIPK4 | 1.79821482 |
| 18 | IKBKE | 1.78749943 |
| 19 | TAOK1 | 1.77520421 |
| 20 | TAOK2 | 1.75379373 |
| 21 | WNK4 | 1.67526832 |
| 22 | DYRK1B | 1.59970842 |
| 23 | PRPF4B | 1.59519604 |
| 24 | JAK1 | 1.55552984 |
| 25 | CHUK | 1.52204091 |
| 26 | IRAK1 | 1.50847404 |
| 27 | FGFR4 | 1.50793609 |
| 28 | KIT | 1.44433449 |
| 29 | MAP3K13 | 1.43132336 |
| 30 | CDC42BPA | 1.42685744 |
| 31 | STK38 | 1.36531126 |
| 32 | JAK3 | 1.36497830 |
| 33 | STK39 | 1.30348249 |
| 34 | TNK2 | 1.25269381 |
| 35 | MAPK15 | 1.22767408 |
| 36 | TRIB3 | 1.13335687 |
| 37 | NEK2 | 1.12613554 |
| 38 | BLK | 1.12303197 |
| 39 | EPHA3 | 1.11363072 |
| 40 | STK3 | 1.10383033 |
| 41 | MOS | 1.08698857 |
| 42 | CAMK1D | 1.08547498 |
| 43 | CSF1R | 1.07960306 |
| 44 | PKN1 | 1.06387903 |
| 45 | TXK | 1.01263201 |
| 46 | FES | 0.97186922 |
| 47 | ERN1 | 0.96247455 |
| 48 | IRAK4 | 0.92049776 |
| 49 | PDK1 | 0.91454174 |
| 50 | KSR2 | 0.91438488 |
| 51 | PLK4 | 0.88965005 |
| 52 | FLT3 | 0.82871877 |
| 53 | MST1R | 0.80863113 |
| 54 | PRKAA2 | 0.80705787 |
| 55 | CSK | 0.77826837 |
| 56 | MAP3K10 | 0.75415339 |
| 57 | MARK2 | 0.72006433 |
| 58 | SIK2 | 0.70057686 |
| 59 | WNK1 | 0.68758309 |
| 60 | SIK3 | 0.68322135 |
| 61 | PTK6 | 0.68168092 |
| 62 | ARAF | 0.67661330 |
| 63 | IRAK3 | 0.67488577 |
| 64 | ACVR1B | 0.66686314 |
| 65 | RPS6KC1 | 0.66260090 |
| 66 | RPS6KL1 | 0.66260090 |
| 67 | RPS6KA2 | 0.65611257 |
| 68 | TAOK3 | 0.64558668 |
| 69 | MAP4K1 | 0.63709269 |
| 70 | JAK2 | 0.61951215 |
| 71 | PDPK1 | 0.61162375 |
| 72 | PIM1 | 0.60405466 |
| 73 | ZAP70 | 0.60388227 |
| 74 | TGFBR2 | 0.58713113 |
| 75 | RPS6KA6 | 0.56489228 |
| 76 | IRAK2 | 0.54974692 |
| 77 | TESK2 | 0.54587712 |
| 78 | PRKG2 | 0.54250276 |
| 79 | PNCK | 0.53450560 |
| 80 | CAMK1G | 0.51893582 |
| 81 | FGFR3 | 0.50212916 |
| 82 | DYRK3 | 0.49118610 |
| 83 | CDK12 | 0.48043468 |
| 84 | LCK | 0.47833583 |
| 85 | TTN | 0.47410567 |
| 86 | CDK6 | 0.46910706 |
| 87 | DAPK2 | 0.45285278 |
| 88 | ADRBK2 | 0.44352416 |
| 89 | PRKD2 | 0.42651362 |
| 90 | EGFR | 0.42289490 |
| 91 | NEK9 | 0.41257326 |
| 92 | SYK | 0.40802964 |
| 93 | MAP2K6 | 0.40406860 |
| 94 | MAPK7 | 0.40326366 |
| 95 | TYRO3 | 0.39502150 |
| 96 | PIM2 | 0.39357673 |
| 97 | HCK | 0.37870281 |
| 98 | MAP3K8 | 0.37413374 |
| 99 | CAMKK2 | 0.37377396 |
| 100 | GRK6 | 0.36470234 |
| 101 | PRKCD | 0.36187342 |
| 102 | STK4 | 0.35071731 |
| 103 | PRKCQ | 0.34996588 |
| 104 | MAPK4 | 0.33684371 |
| 105 | BMX | 0.31655488 |
| 106 | RPS6KA1 | 0.30546809 |
| 107 | STK10 | 0.30506189 |
| 108 | GSK3A | 0.30240790 |
| 109 | FGR | 0.29994838 |
| 110 | MAP3K2 | 0.29772800 |
| 111 | MTOR | 0.29689123 |
| 112 | FYN | 0.29236618 |
| 113 | MAP2K2 | 0.29147411 |
| 114 | MARK3 | 0.29080760 |
| 115 | RPS6KA4 | 0.28807604 |
| 116 | LATS2 | 0.28760889 |
| 117 | PAK4 | 0.27486998 |
| 118 | RIPK1 | 0.27094741 |
| 119 | PRKAA1 | 0.25823920 |
| 120 | PRKCZ | 0.25819204 |
| 121 | MAP3K3 | 0.25003605 |
| 122 | BTK | 0.24267832 |
| 123 | PAK1 | 0.22558631 |
| 124 | MAP2K3 | 0.21585306 |
| 125 | ABL1 | 0.20481617 |
| 126 | BMPR2 | 0.16276707 |
| 127 | MAPKAPK2 | 0.16244497 |
| 128 | LYN | 0.14594553 |
| 129 | MAP3K1 | 0.14567479 |
| 130 | MATK | 0.14004842 |
| 131 | SIK1 | 0.12638211 |
| 132 | PAK2 | 0.12359973 |
| 133 | PDGFRB | 0.11661665 |
| 134 | PRKACG | 0.11635047 |
| 135 | SGK1 | 0.09706869 |
| 136 | MAP3K5 | 0.09224834 |
| 137 | STK38L | 0.09134066 |
| 138 | ABL2 | 0.08317303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.10780264 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77649582 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.73638759 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.49825869 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.29979289 |
| 6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.07390881 |
| 7 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.00649842 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95362270 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95087855 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91026366 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87980716 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.87762685 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85520596 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82276145 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.82058753 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.76175611 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.72872450 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68346405 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67986990 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63704596 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55549187 |
| 22 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.53373941 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53246324 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48317957 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45681687 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.45558534 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45502136 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45260465 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45113375 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.44709194 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.44288126 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.42909631 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40051496 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.39344252 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.38347678 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33646618 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29313700 |
| 38 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.26888647 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24951865 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.23778532 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23727431 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.23264321 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.20866533 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09218930 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08113617 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07506024 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.06777069 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05784582 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05625468 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.05405707 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.03446304 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03332183 |
| 53 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02117516 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01546315 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01066113 |
| 56 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99703488 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.97171207 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.94131914 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92186330 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90422159 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87256412 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.87028056 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86785559 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85707115 |
| 65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.84134772 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.83191580 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.82008289 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80991696 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80053656 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.80024374 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79355740 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79114932 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.78834386 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.78736418 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76920971 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75174186 |
| 77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74104399 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72517704 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.72344686 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.71505228 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70277590 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70190888 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70179264 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.69425415 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.69120286 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68249432 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68129382 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.66854400 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66492757 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66122392 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.65718195 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64822108 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63501045 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60991153 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60860493 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60463673 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60377057 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58545626 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57877854 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56813072 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55363503 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55195874 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53764802 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53021636 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51021315 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50623422 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50077731 |
| 108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49349594 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.47423433 |
| 110 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46450333 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45654714 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44861256 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44435078 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44032836 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43628923 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42817791 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.42710048 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42409770 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41574548 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39202201 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38479918 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37754105 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37045327 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36948520 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36615924 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35817501 |
| 127 | Carbon metabolism_Homo sapiens_hsa01200 | 0.35736216 |
| 128 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34976374 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34537993 |
| 130 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30434525 |
| 131 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29342667 |
| 132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27816445 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26787210 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26232841 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25995304 |
| 136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.24768016 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24129079 |
| 138 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22271265 |

